Item
Echinacea 4 % (17055)
Echinacea purpurea Extract 95%
Maltodextrin 5%
Herb
Attributes
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| Huisong Pharmaceuticals | Please fill in ?, N/A ? CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | Huisong Pharmaceuticals | Allergens.pdf | 1/31/2020 | 1/30/2022 |
| Country of Origin | Huisong Pharmaceuticals | Country of Origin.pdf | 10/28/2020 | 10/28/2023 |
| Label Sample | Huisong Pharmaceuticals | Label Echinacea Purpura Extract 4 EP102 ex Huisong 28082019.pdf | 8/28/2019 | 8/27/2020 |
| GMO | Huisong Pharmaceuticals | NotApplicable_GMO.pdf | 5/7/2021 | 5/7/2023 |
| GRAS/NDI/ODI Statement | Huisong Pharmaceuticals | NotApplicable_GRASNDIODIStatement.pdf | 12/14/2023 | 12/13/2026 |
| Ingredient Statement | Huisong Pharmaceuticals | NotApplicable_IngredientStatement.pdf | 5/7/2021 | 5/7/2022 |
| Irradiation Status Statement | Huisong Pharmaceuticals | NotApplicable_IrradiationStatusStatement.pdf | 5/7/2021 | 5/7/2023 |
| No Animal Ingredient Statement | Huisong Pharmaceuticals | NotApplicable_NoAnimalIngredientStatement.pdf | 11/2/2020 | 11/2/2021 |
| Residual Statement | Huisong Pharmaceuticals | NotApplicable_ResidualStatement.pdf | 11/2/2020 | 11/2/2021 |
| Safety Data Sheet (SDS) | Huisong Pharmaceuticals | NotApplicable_SafetyDataSheetSDS.pdf | 5/7/2021 | 5/7/2023 |
| Shelf Life | Huisong Pharmaceuticals | Product Specification Echinacea Purpura Extract 4 EP102 ex Huisong 26082019.pdf | 8/26/2019 | 8/25/2021 |
| California Prop. 65 | Huisong Pharmaceuticals | Prop 65 Statement Echinacea Purpura Extract 4 EP102 ex Huisong 28082019.pdf | 8/28/2019 | 8/27/2021 |
| CoA Sample | Huisong Pharmaceuticals | Typical CoA - Echinacea extract 4% ex Huisong.pdf | 6/11/2019 | 6/10/2021 |
| WADA/NSF/NFL Statement | Huisong Pharmaceuticals | WADA Statement Rev 2019 EP102.pdf | 1/31/2020 | 1/30/2022 |
